Medicare Enrolled
Dr. Mark Cascione, M.D.
Neurology · Tampa, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cascione from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cascione?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cascione
Dr. Mark Cascione is a neurology specialist in Tampa, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cascione performed 37,165 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Cascione received a total of $1,472,209 from 105 pharmaceutical and/or device companies across 3548 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cascione is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in FL
$1,472,209 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 70673 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗37,165
Medicare services
Top 3% in FL for neurology
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Ocrelizumab infusion (Ocrevus) for MS | 36,600 | $46 | $121 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
130 | $97 | $614 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
129 | $123 | $788 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
112 | $21 | $106 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
78 | $85 | $562 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
62 | $4 | $21 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
29 | $12 | $96 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $48 | $397 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
98.8% high complexity
0.5% medium
0.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,472,209
Total received (2018-2024)
Avg $210,316/year across 7 years
Top 0% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
105
Companies
3,548
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$132,504
2023
$164,544
2022
$221,128
2021
$143,686
2020
$85,788
2019
$343,078
2018
$381,482
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$29,922
GENZYME CORPORATION
$26,885
TG Therapeutics, Inc.
$25,447
Biogen, Inc.
$24,182
Vanda Pharmaceuticals Inc.
$8,145
Novartis Pharmaceuticals Corporation
$6,082
Celgene Corporation
$3,944
EMD Serono, Inc.
$2,621
ABBVIE INC.
$550
PFIZER INC.
$514
Octapharma USA, Inc.
$428
Genentech USA, Inc.
$375
Lundbeck LLC
$357
UCB, Inc.
$324
Alexion Pharmaceuticals, Inc.
$288
ARGENX US, INC.
$277
Amgen Inc.
$275
Eisai Inc.
$261
Lilly USA, LLC
$200
Neurocrine Biosciences, Inc.
$195
Takeda Pharmaceuticals U.S.A., Inc.
$188
Otsuka America Pharmaceutical, Inc.
$157
Mallinckrodt Hospital Products Inc.
$148
Genentech, Inc.
$141
ACADIA Pharmaceuticals Inc
$95
Merz Pharmaceuticals, LLC
$77
SK Life Science, Inc.
$66
CSL Behring
$51
Azurity Pharmaceuticals, Inc.
$42
LivaNova USA, Inc.
$41
Sandoz Inc.
$39
Mylan Specialty L.P.
$36
Teva Pharmaceuticals USA, Inc.
$32
Averitas Pharma Inc.
$27
Acorda Therapeutics, Inc
$26
Janssen Pharmaceuticals, Inc
$24
Boston Scientific Corporation
$22
Cycle Pharmaceuticals Inc
$21
Top 3 companies account for 62.1% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$475,952
Biogen, Inc.
$214,454
Genentech USA, Inc.
$214,424
E.R. Squibb & Sons, L.L.C.
$147,564
EMD Serono, Inc.
$105,588
Novartis Pharmaceuticals Corporation
$56,281
Celgene Corporation
$55,780
TG THERAPEUTICS, INC.
$43,665
Alexion Pharmaceuticals, Inc.
$41,441
Janssen Pharmaceuticals, Inc
$31,777
SANOFI-AVENTIS U.S. LLC
$27,000
TG Therapeutics, Inc.
$25,962
Vanda Pharmaceuticals Inc.
$8,226
Amgen Inc.
$1,446
AbbVie, Inc.
$1,419
Teva Pharmaceuticals USA, Inc.
$1,347
UCB, Inc.
$1,222
Lundbeck LLC
$1,148
Allergan, Inc.
$954
ABBVIE INC.
$940
Lilly USA, LLC
$877
PFIZER INC.
$834
Acorda Therapeutics, Inc
$711
Genentech, Inc.
$710
Octapharma USA, Inc.
$695
Adamas Pharmaceuticals, Inc.
$688
AbbVie Inc.
$616
Neurocrine Biosciences, Inc.
$588
Otsuka America Pharmaceutical, Inc.
$573
Takeda Pharmaceuticals U.S.A., Inc.
$536
Biohaven Pharmaceuticals, Inc.
$524
ARGENX US, INC.
$519
Sunovion Pharmaceuticals Inc.
$489
Horizon Therapeutics plc
$487
Allergan Inc.
$486
Avanir Pharmaceuticals, Inc.
$448
Amneal Pharmaceuticals LLC
$324
CSL Behring
$321
Eisai Inc.
$302
Supernus Pharmaceuticals, Inc.
$299
ACADIA Pharmaceuticals Inc
$282
Mallinckrodt Hospital Products Inc.
$277
UPSHER-SMITH LABORATORIES LLC
$238
Biohaven Pharmaceutical Holding Company Ltd.
$220
BANNER LIFE SCIENCES, LLC
$195
MDD US Operations, LLC
$170
GE Healthcare
$169
ARBOR PHARMACEUTICALS, INC.
$160
Upsher-Smith Laboratories LLC
$149
GE HealthCare
$143
Assertio Therapeutics, Inc.
$132
US WorldMeds, LLC
$132
Harmony Biosciences LLC
$119
Merz Pharmaceuticals, LLC
$117
Mallinckrodt LLC
$113
Sumitomo Pharma America, Inc.
$113
Bayer HealthCare Pharmaceuticals Inc.
$112
Impax Laboratories, Inc.
$106
JAZZ PHARMACEUTICALS INC.
$98
Akcea Therapeutics, Inc.
$89
Arbor Pharmaceuticals, Inc.
$84
Bausch Health US, LLC
$81
Neurelis, Inc.
$77
SK Life Science, Inc.
$66
GE HEALTHCARE
$61
Azurity Pharmaceuticals, Inc.
$58
Averitas Pharma Inc.
$57
Jazz Pharmaceuticals Inc.
$57
HARMONY BIOSCIENCES LLC
$57
MERZ NORTH AMERICA, INC.
$54
AstraZeneca Pharmaceuticals LP
$52
Almatica Pharma LLC
$42
LivaNova USA, Inc.
$41
Sandoz Inc.
$39
GRT US Holding, Inc.
$39
Egalet US Inc
$38
TerSera Therapeutics LLC
$37
Mylan Specialty L.P.
$36
Zyla Life Sciences, Inc.
$30
Banner Life Sciences, LLC
$30
Grifols USA, LLC
$27
Zyla Life Sciences
$26
Bioventus LLC
$24
Corium, LLC
$24
Merz North America, Inc.
$23
Boston Scientific Corporation
$22
Cycle Pharmaceuticals Inc
$21
IMPEL PHARMACEUTICALS INC.
$19
Xeris Pharmaceuticals, Inc.
$18
MITSUBISHI TANABE PHARMA AMERICA, INC.
$17
Scilex Pharmaceuticals Inc.
$17
Penumbra, Inc.
$16
ASSERTIO THERAPEUTICS, Inc.
$16
Mylan Pharmaceuticals Inc.
$15
InSightec,Inc
$14
Medtronic USA, Inc.
$14
Collegium Pharmaceutical, Inc.
$14
Dynasplint Systems Inc.
$13
Avion Pharmaceuticals
$13
Kyowa Kirin, Inc.
$13
Promius Pharma LLC
$12
Currax Pharmaceuticals LLC
$12
PORTOLA PHARMACEUTICALS, INC.
$12
Mallinckrodt Enterprises LLC
$11
Piramal Imaging Limited
$10
Top 3 companies account for 61.5% of all-time payments
Associated products mentioned in payments ›
ACE · ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · COMIRNATY · CONTRAVE · COPAXONE · CUTAQUIG · Cambia · DISEASE STATE · DUOPA · Dhivy · Duopa · Dynasplint · ELYXYB - celecoxib · EMGALITY · EVUSHELD · Enspryng · Evrysdi · Exablate · GAMMAGARD · GILENYA · GLATIRAMER ACETATE · GOCOVRI · GRALISE · GVOKE PFS · Gamunex-C · Glatiramer Acetate · Gralise · HETLIOZ · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · L300 Go System · LEMTRADA · LUMIZYME · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MS DISEASE STATE · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · Ocrevus · Ocrevus Zunovo · Ongentys · Ozanimod · PANZYGA · PLEGRIDY · POMPE - DISEASE · PONVORY · PRIALT · Ponvory · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · Quzyttir · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SPRAVATO · SPRIX · SUNOSI · SYNCHROMED · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tascenso ODT · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XADAGO · XEOMIN · XYWAV · Xadago · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
183
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA SOUTH TAMPA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cascione is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cascione experienced with ocrelizumab infusion (ocrevus) for ms?
Based on Medicare claims data, Dr. Cascione performed 36,600 ocrelizumab infusion (ocrevus) for ms services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Cascione receive payments from pharmaceutical companies?
Yes. Dr. Cascione received a total of $1,472,209 from 105 companies across 3,548 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cascione's costs compare to other neurologists in Tampa?
Dr. Cascione's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cascione) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Tampa
Browse neurologists in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology